Shaygannejad V - Search Results

1

Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.

Barzegar M, Vaheb S, Mirmosayyeb O, Ashtari F, Afshari-Safavi A, Adibi I, Shaygannejad A, Mazaheri S, Rahimi M, Shaygannejad V. Barzegar M, et al. Among authors: shaygannejad a, shaygannejad v. Mult Scler Relat Disord. 2024 Apr;84:105479. doi: 10.1016/j.msard.2024.105479. Epub 2024 Feb 1. Mult Scler Relat Disord. 2024. PMID: 38359695

2

Prevalence of multiple sclerosis in Isfahan, Iran.

Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Etemadifar M, et al. Among authors: shaygannejad v. Neuroepidemiology. 2006;27(1):39-44. doi: 10.1159/000094235. Epub 2006 Jun 27. Neuroepidemiology. 2006. PMID: 16804333

3

Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.

Maghzi AH, Etemadifar M, Shaygannejad V, Saadatnia M, Salehi M, Hassanzadeh A. Maghzi AH, et al. Among authors: shaygannejad v. Mult Scler. 2007 Jun;13(5):673-5. doi: 10.1177/1352458506072092. Epub 2007 Feb 9. Mult Scler. 2007. PMID: 17548450

4

A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.

Ashtari F, Shaygannejad V, Akbari M. Ashtari F, et al. Among authors: shaygannejad v. Acta Neurol Scand. 2008 Nov;118(5):301-5. doi: 10.1111/j.1600-0404.2008.01087.x. Acta Neurol Scand. 2008. PMID: 18713156 Clinical Trial.

5

Effects of rivastigmine on memory and cognition in multiple sclerosis.

Shaygannejad V, Janghorbani M, Ashtari F, Zanjani HA, Zakizade N. Shaygannejad V, et al. Can J Neurol Sci. 2008 Sep;35(4):476-81. doi: 10.1017/s0317167100009148. Can J Neurol Sci. 2008. PMID: 18973065 Clinical Trial.

6

Short-term effects of prolonged fasting on multiple sclerosis.

Saadatnia M, Etemadifar M, Fatehi F, Ashtari F, Shaygannejad V, Chitsaz A, Maghzi AH. Saadatnia M, et al. Among authors: shaygannejad v. Eur Neurol. 2009;61(4):230-2. doi: 10.1159/000197108. Epub 2009 Jan 29. Eur Neurol. 2009. PMID: 19176964

7

Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation.

Chitsaz A, Janghorbani M, Shaygannejad V, Ashtari F, Heshmatipour M, Freeman J. Chitsaz A, et al. Among authors: shaygannejad v. Clin J Pain. 2009 May;25(4):281-5. doi: 10.1097/AJP.0b013e318190862b. Clin J Pain. 2009. PMID: 19590475 Clinical Trial.

8

Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?

Ashtari F, Fatehi F, Shaygannejad V, Chitsaz A. Ashtari F, et al. Among authors: shaygannejad v. Neurol Neurochir Pol. 2009 Sep-Oct;43(5):428-32. Neurol Neurochir Pol. 2009. PMID: 20054744 Clinical Trial.

9

Effects of adjunct glucosamine sulfate on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized, placebo-controlled trial.

Shaygannejad V, Janghorbani M, Savoj MR, Ashtari F. Shaygannejad V, et al. Neurol Res. 2010 Nov;32(9):981-5. doi: 10.1179/016164110X12656393664964. Epub 2010 Mar 10. Neurol Res. 2010. PMID: 20223094 Clinical Trial.

10

Does early-onset multiple sclerosis differ from adult-onset form in Iranian people.

Ashtari F, Shaygannejad V, Farajzadegan Z, Amin A. Ashtari F, et al. Among authors: shaygannejad v. J Res Med Sci. 2010 Mar;15(2):94-9. J Res Med Sci. 2010. PMID: 21526065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters